Stockscreener 앱 받기
3.2346
0.46%
-0.0154
전일 마감가:
$3.25
열려 있는:
$3.22
하루 거래량:
150.88K
Relative Volume:
0.43
시가총액:
$256.69M
수익:
$351.37M
순이익/손실:
$-174.01M
주가수익비율:
-1.5626
EPS:
-2.07
순현금흐름:
$-126.94M
1주 성능:
-0.46%
1개월 성능:
+11.56%
6개월 성능:
+8.56%
1년 성능:
-1.67%
1일 변동 폭
$3.15
$3.26
1주일 범위
$3.15
$3.335
52주 변동 폭
$2.455
$4.02
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
명칭
Atea Pharmaceuticals Inc
전화
857-204-8109
주소
225 FRANKLIN STREET, BOSTON
AVIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.2346 | 257.91M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.13 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.15 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.61 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | 개시 | Evercore ISI | Outperform |
| 2020-11-24 | 개시 | JP Morgan | Overweight |
| 2020-11-24 | 개시 | Morgan Stanley | Overweight |
| 2020-11-24 | 개시 | William Blair | Outperform |
모두보기
Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스
Is Atea Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Backtesting results for Atea Pharmaceuticals Inc. trading strategiesEarnings Beat & Risk Managed Investment Entry Signals - newser.com
Is a relief rally coming for Atea Pharmaceuticals Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Live market analysis of Atea Pharmaceuticals Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Is Atea Pharmaceuticals Inc. still worth holding after the dipBuy Signal & Consistent Return Investment Signals - newser.com
Atea Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Update & Verified Momentum Watchlists - newser.com
Key metrics from Atea Pharmaceuticals Inc.’s quarterly dataJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Is Atea Pharmaceuticals Inc. stock cheap at current valuation2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
Atea Pharmaceuticals, Inc. (AVIR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Atea Pharmaceuticals Advances with Key Phase 1 Study on Bemnifosbuvir/Ruzasvir - MSN
Atea Pharmaceuticals Inc Stock Analysis and ForecastFlag and Pennant Patterns & Outstanding Portfolio Growth - earlytimes.in
Atea Pharmaceuticals, Inc. (AVIR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Atea Pharmaceuticals (AVIR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Applying sector rotation models to Atea Pharmaceuticals Inc.Weekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Using economic indicators to assess Atea Pharmaceuticals Inc. potentialMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
What drives Atea Pharmaceuticals Inc stock priceDividend Reinvestment Plans & Free Fastest Return On Investment - earlytimes.in
Will Atea Pharmaceuticals Inc. stock split attract more investorsIPO Watch & Daily Profit Maximizing Trade Tips - fcp.pa.gov.br
Will Atea Pharmaceuticals Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Entry Point Alerts - fcp.pa.gov.br
Atea Pharmaceuticals’ New HCV Study: Potential Game-Changer? - TipRanks
Atea Pharmaceuticals’ Promising HCV Treatment Study: Key Insights for Investors - TipRanks
Custom strategy builders for tracking Atea Pharmaceuticals Inc.Dollar Strength & Capital Efficiency Focused Ideas - newser.com
Atea Pharmaceuticals Inc (AVIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Atea Pharmaceuticals Inc 주식 (AVIR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
0.15%
1.71%
자본화:
|
볼륨(24시간):